Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

ClinicalTrials.gov ID: NCT07804615

Public ClinicalTrials.gov record NCT07804615. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 9:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study to Evaluate the Efficacy, Pharmacokinetics, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Vista PD is a randomized, placebo-controlled, multicenter study to evaluate the efficacy, PK, safety, and tolerability of VIM0423 in adults with Parkinson's disease tremor insufficiently responsive to dopaminergic therapy. The main objectives of this clinical trial are to determine the following: * Does VIM0423 therapy improve tremor symptoms in adults with Parkinson's disease? * Is VIM0423 well tolerated in individuals with Parkinsons's disease? and * Do the therapeutic effects of VIM0423 confer improvements on daily function and quality of life?

Study identification

NCT ID
NCT07804615
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vima Therapeutics
Industry
Enrollment
80 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2026 (Estimated)
Primary completion
Jun 2027 (Estimated)
Completion
Jun 2027 (Estimated)
Last update posted
Sep 11, 2026

2026 – 2027

United States locations

U.S. sites
29
U.S. states
16
U.S. cities
28
Facility City State ZIP Site status
Vima Site #039 Scottsdale Arizona 85251 Not yet recruiting
Vima Site #064 Scottsdale Arizona 85258 Not yet recruiting
Vima Site #048 Murrieta California 92562 Not yet recruiting
Vima Site #050 Stamford Connecticut 06905 Not yet recruiting
Vima Site #065 Altamonte Springs Florida 32714 Not yet recruiting
Vima Site #054 Aventura Florida 33180 Not yet recruiting
Vima Site #008 Miami Florida 33176 Not yet recruiting
Vima Site #046 Naples Florida 34105 Not yet recruiting
Vima Site #053 Palm Beach Florida 33407 Not yet recruiting
Vima Site #062 Tampa Florida 33602 Not yet recruiting
Vima Site #047 Atlanta Georgia 30328 Not yet recruiting
Vima Site #045 Decatur Georgia 30030 Not yet recruiting
Vima Site #041 Overland Park Kansas 66211 Not yet recruiting
Vima Site #043 Baltimore Maryland 21237 Not yet recruiting
Vima Site #007 Olney Maryland 20832 Not yet recruiting
Vima Site #002 Farmington Hills Michigan 48334 Recruiting
Vima Site #014 Albuquerque New Mexico 87106 Not yet recruiting
Vima Site #055 Amherst New York 14226 Not yet recruiting
Vima Site #024 New York New York 10019 Not yet recruiting
Vima Site #052 Patchogue New York 11772 Not yet recruiting
Vima Site #067 Raleigh North Carolina 27607 Not yet recruiting
Vima Site #051 Canton Ohio 44718 Not yet recruiting
Vima Site #016 Memphis Tennessee 38157 Not yet recruiting
Vima Site #049 Cypress Texas 77429 Not yet recruiting
Vima Site #063 Dallas Texas 75243 Not yet recruiting
Vima Site #058 Round Rock Texas 78681 Not yet recruiting
Vima Site #066 Arlington Virginia 22205 Not yet recruiting
Vima Site #023 Kirkland Washington 98034 Not yet recruiting
Vima Site #015 Spokane Washington 99202 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07804615, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 11, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07804615 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →